ATH-T 0.08 ARX-T 0.34 NVA-T 0.17 CGRE-T 0.3 RIT-T 0.16 ZRE-T 0.3
Daily Stock Opinions and Ratings
Stockchase Opinions

Jim Cramer - Mad Money AbCellera Biologics ABCL-Q DON'T BUY Nov 12, 2021

This biotech is purely speculative. He ain't playin'.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$15.040

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

RISKY

AbCellera Biologics(ABCL-Q)

Sep 22, 2021
It's a spec play, but he likes the biologics space.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$21.340

Stock price when the opinion was issued

biotechnology
COMMENT

AbCellera Biologics(ABCL-Q)

May 16, 2022
They're okay. Shares have fallen, but the company makes money.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$7.810

Stock price when the opinion was issued

biotechnology

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

HWX-T 0.04$5.47
FRU-T 0.18$11.43
PD-T 0.68$58.75
BTE-T -0.02$2.24
VRN-T -0.04$8.01
Advertising

Today's Top Picks

ATH-T 0.08$4.6
ARX-T 0.34$25.75
NVA-T 0.17$11.57
CGRE-T 0.3$20.26
RIT-T 0.16$15.19

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

OXY-N -0.1$37.8
PNE-T 0.01125$0.6
CEU-T -0.01$6
PXT-T -0.07$11.03
TOU-T -0.03$60.71

Most Recent Experts

Eric Nuttall

Ninepoint Partners

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

David Burrows

Barometer Capital Management

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research

Advertising
Advertising
© Stockchase Inc.